Structured JSON API for this factor page: https://sharemaestro.com/factors/api/tickers/abad14e6-13b8-4a6a-b92c-e516cbbdc9aa/

PLSE

Pulse Biosciences Inc
Chart
$25.33
Latest Week 2026-06-05
Snapshot 2026-06-07 · 0.0w · Fresh
0.09
OS Score
14.0%
Value
5.0%
Quality
77.0%
Momentum
1/9
F-Score
0.084
QV
Strategy Eligibility
1 of 23 passing
OS Composite
Trending Value
Quality × Value
🏛
Cornerstone Value
🌿
Cornerstone Growth
💎
Deep Value
VC2 Cheapest
📐
EBITDA/EV
Veiled Value
Piotroski Bargains
🔬
Quality Compounders
📈
Consistent Earners
Noneyr
🌱
GARP
🔄
Shareholder Yield
💰
High Yield
🚀
Momentum Leaders
Market Leaders
Tiny Titans
🔍
Small Cap Value
🛡
Low Volatility
🏷
Sector Cheapest
🧠
Capital Allocators
Risk-Adj Momentum
V
Value Analysis
Cheapness relative to fundamentals
14.0%ile
P/S
2286.4×
P/B
25.9×
FCF Yield
-0.033
SH Yield
0.000
Relative Strength Across Value Dimensions
Multiples & Yields — Decomposition
VC1 (5-Factor)
88.00000000
/100 — 1=cheapest
VC2 (Trending Value)
93.00000000
/100
VC3 (Buyback)
93.00000000
/100
Negative FCF yield (-3.3%) — the business is currently cash-consumptive. VC2 score of 93.00000000/100 — expensive across all six composite measures.
Q
Quality Analysis
Profitability, efficiency, balance sheet & earnings quality
5.0%ile
ROE
-1.125
ROA
-0.914
Net Margin
-99.290
Op Margin
-100.048
GPA
-0.008
D/E
0.23
Current
7.26
F-Score
1/9
Quality Radar — Relative Strength
Profitability & Leverage Breakdown
Rev Growth
-0.699
Stability
0.186
lower=better
Accruals
-0.237
lower=better
5yr Consist
Yes
Conservative balance sheet with D/E of 0.23. F-Score of 1/9 flags fundamental deterioration — multiple signals are weakening.
M
Momentum & Risk
Price trend, volatility regime, risk-adjusted returns
77.0%ile
6M Return
90.9%
12M Return
48.1%
12-1 Mom
11.6%
Risk-Adj
0.14
Vol 252d
84.5%
Vol 60d
210.2%
↑ Expanding
Max DD 12M
-32.6%
Return Comparison — 6M / 12M / 12-1
Volatility Regime — 60d vs 252d
Near-term vol (210%) is expanding vs long-term (84%) — risk is increasing.
OS
Composite & Factor Heatmap
All factors at a glance
0.09
Pillar Balance — Value / Quality / Momentum
Factor Heatmap — green=strong, red=weak
Sector Context
Healthcare · 500 peers
Sector Value %ile
5.2%
Sector Quality %ile
1.0%
P/B z-score
1.74
Sector Avg OS
63.3%
Ticker vs Sector Averages
Relative Valuation Z-Score
Top Sector Peers (By OS)
SymbolNameOSValueQualityMomentum
IRWD Ironwood Pharmaceuticals Inc 99.0% 93.0% 86.0% 98.0%
FBIO Fortress Biotech Inc 98.0% 97.0% 93.0% 74.0%
RIGL Rigel Pharmaceuticals Inc 98.0% 94.0% 92.0% 76.0%
CGEN Compugen 97.0% 90.0% 95.0% 76.0%
PBYI Puma Biotechnology Inc 97.0% 80.0% 97.0% 92.0%
FBIOP Fortress Biotech Inc Pref Series A 97.0% 81.0% 95.0% 90.0%
WW WW International, Inc. Common Stock 97.0% 88.0% 80.0% 99.0%
MD Mednax Inc 96.0% 87.0% 80.0% 87.0%
Factor Interactions
Volatility Expanding
60-day vol (210%) significantly exceeds 252-day (84%). Near-term risk is elevated.
Factor Analysis
Comprehensive factor intelligence — strengths, weaknesses & cross-factor profile
Value
F
2.8% avg (4 factors)
Quality
D
36.8% avg (8 factors)
Momentum
B
66.0% avg (4 factors)
Risk
F
0.0% avg (1 factors)
Elevated risk profile — position sizing should reflect the higher volatility.
▲ Top Strengths — highest scoring factors
▼ Key Weaknesses — lowest scoring factors
Factor Persistence1 snapshots
FactorCurrentStreakTrendSpark
OS Composite0.090—1
Value %ile0.140—1
Quality %ile0.050—1
Momentum %ile0.770—1
F-Score1.000—1
Confidence0.818—1
Volatility0.845—1
Value FactorsCheapness relative to fundamentals — lower multiples = cheaper
Price / Sales
2286.41
Price / Book
25.90
FCF Yield
-3.3%
Sales Yield (1/P·S)
0.0005
Shareholder Yield
Div + net buyback / mktcap
0.0%
Quality FactorsProfitability, efficiency, and balance sheet strength
Return on Equity
-112.5%
Return on Assets
-91.4%
Net Margin
-9929.0%
Operating Margin
-10004.8%
Gross Profit / Assets
Novy-Marx GPA
-0.8%
Debt / Equity
0.23
Current Ratio
7.26
Accruals Ratio
(NI-OCF)/Assets — lower=better
-0.237
MomentumPrice trend strength over different horizons
6M Return
90.9%
12M Return
48.1%
12-1 Momentum
Jegadeesh-Titman (skip recent month)
11.6%
Risk-Adjusted Momentum
Mom 12-1 ÷ Vol
0.14
Growth & StabilityEarnings trajectory, consistency, and capital allocation
Revenue Growth (YoY)
-69.9%
Earnings Stability (CV)
Lower = more stable
0.186
5yr Consistent
EPS up every year for 5 years
Yes
Piotroski F-Score
1
Dividend Yield
0.0%
Buyback Yield
0.0%
O'Shaughnessy CompositesValue Composites (WWOWS 4th Ed) — 1=cheapest, 100=most expensive
VC1 (5-factor)
P/E+P/S+P/B+P/CF+EBITDA/EV
88
VC2 (6-factor)
VC1 + Shareholder Yield — used for Trending Value
93
VC3 (6-factor)
VC1 + Buyback Yield — no dividend preference
93
Capital Allocation & AlphaAlpha within factors — quality of management decisions
Veiled Value
Expensive by P/B, cheap by everything else
No
Market Leader
Above-avg mcap+revenue, non-utility
No
All Stocks Universe
Market cap > $200M
Yes
Tiny Titan
Micro-cap, low P/S, positive momentum
No
Quarterly Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity
Annual Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity